论文部分内容阅读
甘精胰岛素与癌症风险在2011年IDF国际糖尿病年会上,关于来得时(甘精胰岛素)的癌症风险问题又有了新的数据。之前,在第34届圣安东尼奥乳腺癌会议(SABCS)上,瑞典隆德大学肿瘤学和癌症流行病学系教授HakanOlsson公布了一项研究结果,该研究把受试者分为甘精胰岛素治疗组(n=1,499)和二甲双胍治疗组(n=8,075),
Ghrelin Insulin and Cancer Risk At the 2011 IDF International Diabetes Conference, new data were also provided on the cancer risk in Bordeaux (insulin glargine). Earlier, at the 34th San Antonio Breast Cancer Conference (SABCS), Hakan Olsson, a professor of oncology and cancer epidemiology at Lund University in Sweden, published a study that classifies subjects into insulin glargine n = 1,499) and metformin-treated group (n = 8,075),